论文部分内容阅读
目的了解该院质子泵抑制剂(PPI)使用情况及趋势。方法对该院2009-2011年PPI主要品种、销售金额、用药频度(DDDs)、日均费用(DDC)进行统计、分析。结果该院PPI销售金额逐年上升,其中泮托拉唑增长较快;3年中DDDs相对波动,奥美拉唑肠溶片、兰索拉唑肠溶片和泮托拉唑肠溶胶囊保持前3位;DDC则维持稳中有降水平。结论该院PPI使用基本合理,但对使用增长加快的品种应注意加强监管。
Objective To understand the use and trend of proton pump inhibitor (PPI) in this hospital. Methods The main PPI varieties, sales amount, DDDs and DDC of the hospital from 2009 to 2011 were statistically analyzed. Results The hospital PPI sales increased year by year, of which pantoprazole increased rapidly; DDDs fluctuated relatively in 3 years, omeprazole enteric-coated tablets, lansoprazole enteric-coated tablets and pantoprazole enteric capsules before 3; DDC is maintained steady decline. Conclusions The PPI use in this hospital is basically reasonable, but it is necessary to pay more attention to the supervision of the varieties that use the accelerated growth.